Fig. 11.

Changes in the defecation days per week of the subjects in the randomized placebo-controlled crossover clinical study. Average increases in defecation days per week during the LF+LB or placebo tablet ingestion period (with the standard error represented by vertical bars) are shown. *p<0.05, **p<0.05, ***p<0.001 (Dunnett’s test compared with the defecation days before the ingestion period). #p<0.05 in the Student’s t-test between the average difference during the LF+LB tablet ingestion period and that during the placebo tablet ingestion period.